Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-002043
Filing Date
2009-03-25
Accepted
2009-03-25 15:40:02
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 CPEX PHARMACEUTICALS, INC. b73480cpe10vk.htm 10-K 776005
2 EX-10.5 LICENSE AGREEMENT DATED MAY 31, 2000 AUXILIUM A2 b73480cpexv10w5.htm EX-10.5 125683
3 EX-10.10 EMPLOYMENT AGREEMENT FRED FELDMAN b73480cpexv10w10.htm EX-10.10 92341
4 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP b73480cpexv23w1.htm EX-23.1 1582
5 EX-31.1 SECTION 302 CERTIFICATION OF CEO b73480cpexv31w1.htm EX-31.1 7895
6 EX-31.2 SECTION 302 CERTIFICATION OF CFO b73480cpexv31w2.htm EX-31.2 7913
7 EX-32.1 SECTION 906 CERTIFICATION OF CEO b73480cpexv32w1.htm EX-32.1 2913
8 EX-32.2 SECTION 906 CERTIFICATION OF CFO b73480cpexv32w2.htm EX-32.2 3231
  Complete submission text file 0000950135-09-002043.txt   1018936
Mailing Address 2 HOLLAND WAY EXETER NH 03833
Business Address 2 HOLLAND WAY EXETER NH 03833 (603) 658-6100
CPEX Pharmaceuticals, Inc. (Filer) CIK: 0001418919 (see all company filings)

EIN.: 261172076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33895 | Film No.: 09703991
SIC: 2834 Pharmaceutical Preparations